M&A

Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

  • by

Last week, the investment arm of Advocate Aurora Health acquired Senior Helpers, the giant home care franchise organization that domestically operates across 44 states. Advocate Aurora Enterprises pulled the trigger on the Maryland-based Senior Helpers as part of its three-pronged investment thesis around aging, parenthood… Read More »Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

Brookdale’s Home Health Business May Look ‘Drastically Different’ Under HCA Healthcare

  • by

In late February, HCA Healthcare (NYSE: HCA) announced it had entered into a definitive agreement to acquire a majority stake in Brookdale Senior Living’s (NYSE: BKD) home health and hospice business. A for-profit operator of health care facilities like HCA wanting to ride home health… Read More »Brookdale’s Home Health Business May Look ‘Drastically Different’ Under HCA Healthcare

Mission Healthcare Purchases Loma Linda University Medical Center’s Home Health Segment

  • by

Mission Healthcare has acquired Loma Linda University Medical Center Home Health in Southern California. Loma Linda University Medical Center Home Health is a part of Loma Linda University Health, which includes eight professional schools, six hospitals and a network of more than 900 faculty physicians.… Read More »Mission Healthcare Purchases Loma Linda University Medical Center’s Home Health Segment

[Updated] ‘We Own the Full Health Care Continuum’: Advocate Aurora Enterprises Acquires Senior Helpers

  • by

One of the largest home care organizations in the country has been acquired by one of the nation’s biggest health systems. Advocate Aurora Enterprises — the recently established subsidiary of Midwest-based Advocate Aurora Health, one of the 12 largest not-for-profit, integrated health systems in the… Read More »[Updated] ‘We Own the Full Health Care Continuum’: Advocate Aurora Enterprises Acquires Senior Helpers

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

  • by

Shots: Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology, single-cell technologies and machine learning The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery, prioritization, and… Read More »Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

Rumored Appriss Acquisition Values Care Collaboration Company PatientPing at $500M

  • by

Care collaboration software platform PatientPing has reportedly been acquired. Boston-based PatientPing provides a wide range of services, including real-time notifications when patients receive care, COVID-19-monitoring tools and other solutions. The software company works with health care organizations across the continuum of care, from hospitals and… Read More »Rumored Appriss Acquisition Values Care Collaboration Company PatientPing at $500M

Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

  • by

Shots: Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21 BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston… Read More »Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

EVV Difficulties Creating M&A Opportunities for Addus HomeCare Corporation

  • by

Over the last few months, Addus HomeCare Corporation (Nasdaq: ADUS) has had to deal with a challenging legislative environment and significant COVID-19 surges that have affected clients and caregivers alike. Still, the Frisco, Texas-based in-home care provider is maintaining its course, particularly when it comes… Read More »EVV Difficulties Creating M&A Opportunities for Addus HomeCare Corporation

Pharos-Backed Charter Buys Physmed Home Health Care; SCAN Group Invests in Monogram

  • by

The hot start to the 2021 dealmaking season continues. Pharos Capital announced on Tuesday that its post-acute care provider platform, Charter Health Care Group, has acquired two home health and hospice assets in Omaha, Nebraska. Financial terms of the transaction were not disclosed. Founded in… Read More »Pharos-Backed Charter Buys Physmed Home Health Care; SCAN Group Invests in Monogram

In-Home Care Providers ConcertoHealth, Perfect Health Merge to Form ‘ConcertoCare’

  • by

Two in-home care providers — ConcertoHealth and Perfect Health — announced Wednesday that their organizations have merged. Together, the companies will operate under the name “ConcertoCare.” Aliso Viejo, California-based ConcertoHealth is a value-based care provider organization that delivers a variety of home-based care services. The… Read More »In-Home Care Providers ConcertoHealth, Perfect Health Merge to Form ‘ConcertoCare’

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

  • by

Shots: Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close in H2’21 The divestiture will allow Lonza to refocus its business as a pure-play partner to the healthcare industry Lonza’s… Read More »Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Carlyle Group, Brighton Park Capital Invest $200M in Indian Health Tech Provider Indegene to Fuel Global Expansion

  • by

What You Should Know: – The Carlyle Group and Brighton Park Capital invests $200M in Bangalore, India-based Indegene to accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions. – Founded in 1998 by five first-generation entrepreneurs, Indegene has emerged as the leading… Read More »Carlyle Group, Brighton Park Capital Invest $200M in Indian Health Tech Provider Indegene to Fuel Global Expansion

Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens

  • by

Shots: Cardiff University will receive milestone payments that advance from the discovery collaboration into clinical development and royalty payments on sales of any products that reach the market. Ervaxx will fund this program Ervaxx gains an exclusive license to Cardiff University patents claiming T cells… Read More »Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens

Accolade to acquire second-opinion platform for $460M

  • by

Benefits navigation startup Accolade acquired second opinion startup 2nd.MD for $460 million. With little overlap between the two companies, the deal is expected to increase Accolade’s total addressable market by $22 billion.

The Pennant Group Acquires Arizona Home Health Provider; Caring People Lands Multiple Home Care Companies

  • by

Pennant kicks off 2021 M&A activity The Pennant Group Inc. (Nasdaq: PNTG) has kicked off its 2021 M&A push. The Eagle, Idaho-based post-acute care provider announced Tuesday it has acquired Sacred Heart Home Health Care, which provides home health services in Phoenix and Tucson, Arizona.… Read More »The Pennant Group Acquires Arizona Home Health Provider; Caring People Lands Multiple Home Care Companies

Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization

  • by

What You Should Know: – Private equity firm Advent International announced that it has completed a recapitalization of RxBenefits, the employee benefits industry’s first and only technology-enabled pharmacy benefits optimizer (PBO). – The transaction values RxBenefits at approximately $1.1 billion. Advent International (“Advent”), one of the… Read More »Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization

Health-tech funding breaks another record in 2020

  • by

Healthcare technology companies raised a record of $15.3 billion in 2020, according to a report from Silicon Valley Bank. For the first time, digital health companies surpassed biopharma for the number of deals.  

Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for Vaccines, Treatments and Diagnostics

  • by

Shots: The acquisition will integrate AmpTec’s PCR-based mRNA technology with Merck’s expertise in lipids manufacturing, providing combine offering across mRNA value chain The deal will expand Merck’s capabilities to develop & manufacture mRNA for use in vaccines, treatments, and diagnostics applicable in COVID-19 and many… Read More »Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for Vaccines, Treatments and Diagnostics

Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology

  • by

Shots: Stryker acquires OrthoSensor and its Verasense intraoperative sensor tech, enhancing the ortho giant’s Mako robots The acquisition allows Stryker to empower surgeons with comprehensive data-driven solutions. The sensor tech will boost Mako surgical robotics systems, enhancing workflow through one complete data-driven feedback mechanism Moreover,… Read More »Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology

LHC Group Finalizes Three Acquisitions; A-1 Preferred Sources Buys On The Mark Services

  • by

LHC Group finalizes hospice, palliative care purchases LHC Group Inc. (Nasdaq: LHCG) has finalized acquisition agreements in Arizona and Oklahoma. By doing so, the Lafayette, Louisiana-based home health, hospice and personal care services giant expands its scope of services in the Phoenix area while entering… Read More »LHC Group Finalizes Three Acquisitions; A-1 Preferred Sources Buys On The Mark Services

Blank-Check Company Deerfield to Combine CareMax, IMC Medical Group in $614M Play

  • by

The health care SPAC boom continues. On Friday, Deerfield Healthcare Technology Acquisitions Corp. (Nasdaq: DFHT) announced it is acquiring CareMax Medical Group and IMC Medical Group Holdings for $364 million and $250 million, respectively. The New York-based Deerfield — a special purpose acquisition company —… Read More »Blank-Check Company Deerfield to Combine CareMax, IMC Medical Group in $614M Play

VC Insider Chris Booker: There’s Definitely More Capital Moving Toward Home-Based Care

  • by

The degree to which venture capitalists were interested in at-home care may have been overplayed at one point. But that’s becoming less and less the case. That’s according to Chris Booker, a partner at the Nashville, Tennessee-based venture capital firm Frist Cressey Ventures, which has… Read More »VC Insider Chris Booker: There’s Definitely More Capital Moving Toward Home-Based Care

Brookdale Senior Living Reportedly Exploring Sale of Home Health and Hospice Businesses

  • by

After falling short on Q3 projections and seeing revenue dip year over year, Brookdale Senior Living (NYSE: BKD) is reportedly considering divesting its home health and hospice segments. COVID-19’s impact on the company has created financial pressures that it hopes to mitigate, PEHub Reported Monday.… Read More »Brookdale Senior Living Reportedly Exploring Sale of Home Health and Hospice Businesses

The Care Team Expands Footprint with InTeliCare Purchase; CareFinders Buys Union Home Care

  • by

The Care Team acquires InTeliCare Private equity-backed The Care Team has acquired InTeliCare Home Health & Hospice. The financial terms of the deal were not disclosed. Farmington Hills, Michigan-based The Care Team is a home-based care provider that delivers a variety of services including nursing,… Read More »The Care Team Expands Footprint with InTeliCare Purchase; CareFinders Buys Union Home Care

Gilead to Acquire MYR for ~$1.4B

  • by

Shots: Gilead to acquire MYR for ~$1.4B in the all-cash transaction along with ~$364.73M as a milestone upon the US FDA’s approval of Hepcludex (bulevirtide) The acquisition will provide Gilead with Hepcludex which has received EMA’s conditional approval for chronic HDV infection in adults with… Read More »Gilead to Acquire MYR for ~$1.4B

Boehringer Ingelheim to Acquires Labor Dr. Merk & Kollegen for Boosting its Next Generation Cancer Immunology Program

  • by

Shots: The acquisition will enable Boehringer Ingelheim to expand and accelerate its comprehensive program for the development of ATMP-based immuno-oncology therapies including the VSV with modified GP platform and cancer vaccines platforms The addition of Labor Dr. Merk & Kollegen’s site will enable Boehringer Ingelheim… Read More »Boehringer Ingelheim to Acquires Labor Dr. Merk & Kollegen for Boosting its Next Generation Cancer Immunology Program

Encompass Health Exploring ‘Strategic Alternatives’ for Home Health, Hospice Segment

  • by

There may soon be a major shakeup of the home health and hospice markets. Encompass Health Corp. (NYSE: EHC) announced Tuesday it is “exploring strategic alternatives” for its home health and hospice business, which brought in total segment revenue of $274.5 million in the third… Read More »Encompass Health Exploring ‘Strategic Alternatives’ for Home Health, Hospice Segment

Elsevier Acquires Shadow Health

  • by

Shots: Elsevier acquires Shadow Health to enhance its extensive portfolio and clinical practice offerings for HCPs during a time of continued growth in telehealth Elsevier works with healthcare educators to prepare students, nursing and HCPs and provide innovative learning tools and analytics that improve educational… Read More »Elsevier Acquires Shadow Health

Looking to Improve Care Coordination, PointClickCare to Buy Collective Medical for Reported $650M

  • by

PointClickCare Technologies has reached an agreement to acquire Collective Medical. The deal is for nearly $650 million, according to Business Insider, which first reported the news on Tuesday. Mississauga, Ontario-based PointClickCare is a cloud-based software vendor for more than 21,000 skilled nursing facilities, senior living… Read More »Looking to Improve Care Coordination, PointClickCare to Buy Collective Medical for Reported $650M

Exactech Acquires Muvr and it’s Digital Health Tech for Orthopedic Practices

  • by

Shots: Exactech has acquired intelligent patient wearables and digital communication solutions maker Muvr Labs to expand its Active Intelligence platform of smart technologies portfolio The Muvr platform includes patient wearables, mobile device applications, and chatbot texting, allowing the surgeons to remotely monitor patient recovery Exactech… Read More »Exactech Acquires Muvr and it’s Digital Health Tech for Orthopedic Practices

Richter Acquires Janssen’s Evra Transdermal Contraceptive Patch Assets for $263.5M

  • by

Shots: Richter signed an asset purchase agreement with Janssen for Evra transdermal contraceptive patch assets outside the US. The total deal value is $263.5M The companies also signed a transitional business license agreement and a series of other related agreements to run the business without… Read More »Richter Acquires Janssen’s Evra Transdermal Contraceptive Patch Assets for $263.5M

Janssen Acquires Rights to Hemera’s HMR59 for Late-Stage Age-Related Macular Degeneration

  • by

Shots: Janssen acquires rights to Hemera’s HMR59, administered as a one-time, outpatient, IVT inj. to help preserve vision in patients with geographic atrophy The acquisition will boost Janssen’s eye disease portfolio & strengthens its gene therapy capabilities HMR59 is designed to increase the ability of… Read More »Janssen Acquires Rights to Hemera’s HMR59 for Late-Stage Age-Related Macular Degeneration

Dr. Reddy’s to Divest Select Anti-Allergy brands to Dr. Reddy’s in Russia and Other CIS Countries

  • by

Shots: Dr. Reddy to acquire Glenmark’s brands Momat Rino (for Russia, Kazakhstan, and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan & Uzbekistan), Glenspray, and Glenspray Active (for Ukraine) along-with rights to the trademarks, dossiers, and patents for the mentioned territories The acquired… Read More »Dr. Reddy’s to Divest Select Anti-Allergy brands to Dr. Reddy’s in Russia and Other CIS Countries

Doctors Making Housecalls CEO: COVID-19 Has Placed an ‘Exclamation Mark’ on House Call Services

  • by

Private equity-backed Eventus WholeHealth recently acquired Doctors Making Housecalls (DMHC), a home-based primary care provider. The deal further highlights the growing interest in home-based primary care seen throughout 2020. Charlotte, North Carolina-based Eventus is a physician-led medical provider for residents and patients of skilled nursing… Read More »Doctors Making Housecalls CEO: COVID-19 Has Placed an ‘Exclamation Mark’ on House Call Services

‘The Clock Is Ticking’: What Addus’ $192M Hospice Deal Means for Home Health M&A

  • by

On last week’s Q3 earnings call, Addus HomeCare Corporation (Nasdaq: ADUS) effectively declared that its “short pause” on M&A activity was officially over. On Wednesday, the company put its money where its mouth is. The Frisco, Texas-based provider announced it has signed an agreement to… Read More »‘The Clock Is Ticking’: What Addus’ $192M Hospice Deal Means for Home Health M&A

Pennant ‘Encouraged’ by Vaccine News, But Not Assuming Near-Term Changes to Home Health Operating Environment

  • by

Home health providers across the board are slowly starting to bounce back from COVID-19-related disruption. One thing that now provides further hope is a potential vaccine, especially as the U.S. continues to break daily records around new infections. The Pennant Group Inc. (Nasdaq: PNTG) is… Read More »Pennant ‘Encouraged’ by Vaccine News, But Not Assuming Near-Term Changes to Home Health Operating Environment

‘These Funds Can Best Be Used Elsewhere’: LHC Group Returns $93.3M in Federal Relief

  • by

Rising demand for health care services delivered in the home and an increasingly favorable regulatory environment have set the stage for the nation’s top-tier home health operators. That idea has LHC Group Inc.’s (Nasdaq: LHCG) leadership team bullish about the company’s near- and long-term outlook.… Read More »‘These Funds Can Best Be Used Elsewhere’: LHC Group Returns $93.3M in Federal Relief

24 Hour Home Care Acquires Grace Care Management, ‘Actively’ Searching for More M&A Opportunities

  • by

In an effort to bolster its at-home care offerings in the San Diego market, 24 Hour Home Care has acquired Grace Care Management, another home care agency located in the area. Since its founding in 2008, Los Angeles-based 24 Hour Home Care has grown quickly… Read More »24 Hour Home Care Acquires Grace Care Management, ‘Actively’ Searching for More M&A Opportunities

Medtronic Expands ENT Portfolio with the Acquisition of Ai Biomed and the Approval of NIM Vital Nerve Monitoring System

  • by

Shots: Medtronic has expanded its portfolio of technologies focusing on improving the safety of head and neck surgeries with the acquisition of Ai Biomed and the US FDA’s 510(k) clearance of NIM Vital nerve monitoring system The NIM Vital nerve monitoring system enables physicians to… Read More »Medtronic Expands ENT Portfolio with the Acquisition of Ai Biomed and the Approval of NIM Vital Nerve Monitoring System

Varsity-Backed Angels of Care Announces Strategic Partnerships, Expands into Three New States

  • by

Angels of Care, a home health provider that specializes in caring for pediatric patients with complex medical conditions, announced Thursday that it has entered into a strategic partnership with Nursing Solutions and Mission Medstaff. Under terms of the strategic partnership, Nursing Solutions and Mission Medstaff… Read More »Varsity-Backed Angels of Care Announces Strategic Partnerships, Expands into Three New States

StageBio Acquires TPL Path Labs to Expand its Footprints Globally

  • by

Shots: StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across the US, EU, and other countries The acquisition expands StageBio’s pre/ clinical laboratory resources, GLP/GCLP-compliant lab facility and staff in… Read More »StageBio Acquires TPL Path Labs to Expand its Footprints Globally

M&A Experts ‘Can’t Recall a Time When Demand Has Been Higher’ in Sizzling In-Home Care Market

  • by

M&A activity across home health, hospice and in-home care appeared to be “business as usual” at the start of 2020. COVID-19 froze the market in March, however, causing both buyers and sellers to bide their time. But dealmaking action is finally starting to heat up… Read More »M&A Experts ‘Can’t Recall a Time When Demand Has Been Higher’ in Sizzling In-Home Care Market

Medicare Advantage Startup Clover Health Slated to Go Public in a $3.7 Billion SPAC Deal

  • by

Clover Health recently announced that it will go public through a merger with a special purpose acquisition company (SPAC), Social Capital Hedosophia Holdings Corp. III. “Going public will enhance our ability to execute on our mission of improving every life, providing significant capital for the… Read More »Medicare Advantage Startup Clover Health Slated to Go Public in a $3.7 Billion SPAC Deal

STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

  • by

Shots:   STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With the acquisition, STADA gain rights to a triple fixed combination (levodopa/carbidopa/ entacapone) delivered via modern… Read More »STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

  • by

Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition complements Binano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The… Read More »Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

The Pennant Group CEO: It’s Too Early to Draw Conclusions About PDGM’s Long-Term Impact

  • by

So far, the transition to the Patient-Driven Groupings Model (PDGM) has gone smoothly for many home health agencies, with a majority successfully avoiding questionable encounters and achieving staffing efficiencies across their operations. Eagle, Idaho-based The Pennant Group Inc. (Nasdaq: PNTG) has seen positive results on… Read More »The Pennant Group CEO: It’s Too Early to Draw Conclusions About PDGM’s Long-Term Impact

Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit

  • by

Shots: The acquisition will expand Medtronic’s capabilities to serve people using multiple daily injections (MDI) to manage diabetes with the addition of Companion Medical’s InPen to Medtronic’s portfolio. The acquisition is expected to be closed within 1-2mos. Medtronic will advance the automation of insights and… Read More »Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit

Bayer to Acquire KaNDy Therapeutics for Augmenting its Women’s Healthcare Portfolio

  • by

Shots: KaNDy to receive $425M upfront, ~$450M milestones until launch followed by additional commercial milestones. The transaction is expected to be completed in Sept’2020 The acquisition will add KaNDy’s menopause drug to Bayer’s portfolio. KaNDy has published results of its NT-814 in P-IIb study that… Read More »Bayer to Acquire KaNDy Therapeutics for Augmenting its Women’s Healthcare Portfolio

LHC Group CFO: Historic Home Health Consolidation Opportunity Remains ‘Compelling as Ever’

  • by

Since the worst stretch of the public health emergency, LHC Group Inc. (Nasdaq: LHCG) has seen a decrease in weekly COVID-related missed visits and improved its average daily census. It has also added thousands of new physician referral sources, a win for the company considering… Read More »LHC Group CFO: Historic Home Health Consolidation Opportunity Remains ‘Compelling as Ever’

COVID-19, PDGM to Drive Home Health Deal Activity Up While Pushing Valuations Down

  • by

The COVID-19 emergency has slowed mergers-and-acquisitions activity in the home-based care space, largely due to travel restrictions, general sector uncertainty and the shifting priorities of top leadership. However, interest in home-based care deals remains robust and valuations remain high. In fact, M&A experts expect deal… Read More »COVID-19, PDGM to Drive Home Health Deal Activity Up While Pushing Valuations Down

Humana Helps Fast-Track In-Home Primary Care Company Heal’s Growth with $100M Investment

  • by

Health and well-being company Humana Inc. (NYSE: HUM) has spent the past few years adding to its health care services portfolio while aggressively investing around a home-based care strategy. The Louisville, Kentucky-based company has now revealed its latest step in that direction. On Wednesday, Humana… Read More »Humana Helps Fast-Track In-Home Primary Care Company Heal’s Growth with $100M Investment

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer

  • by

Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical studies with an IND submission targeted for Aug’2020. The transaction is expected to be close in Aug’2020. The integration of… Read More »Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer

Buyer Beware: Factors Home-Based Care Providers Should Consider Before Acquiring PPP Recipients

Pre-coronavirus, the home health and home care industries were already poised for historic consolidation, thanks to the Patient-Driven Groupings Model (PDGM), rising minimum wages and other operational pressures. Industry leaders predict that the COVID-19 emergency will only drive M&A further going forward. However, home-based care… Read More »Buyer Beware: Factors Home-Based Care Providers Should Consider Before Acquiring PPP Recipients